Biren Amin analyst

Currently out of the existing stock ratings of Biren Amin, 24 are a HOLD (15.79%), 127 are a BUY (83.55%), 1 are a SELL (0.66%).

Biren Amin

Work Performance Price Targets & Ratings Chart

Analyst Biren Amin, currently employed carries an average stock price target met ratio of 55.61% that have a potential upside of 32.6% achieved within 244 days. Previously, Biren Amin worked at JEFFERIES.

Biren Amin’s has documented 310 price targets and ratings displayed on 34 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CCCC, C4 Therapeutics  at 11-Aug-2023.

Wall Street Analyst Biren Amin

Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 5/18/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.35 (10.97%) receiving and performance score of 109.71.

Average potential price target upside

AGEN Agenus ALKS Alkermes Plc ALLO Allogene Therapeutics BLCM Bellicum Pharmaceuticals BLUE Bluebird bio CCCC C4 Therapeutics  CRTX Cortexyme FATE Fate Therapeutics HRTX Heron Therapeuti IMGN ImmunoGen MDCO The Medicines Company NBIX Neurocrine Biosciences NLNK NewLink Genetics REGN Regeneron Pharmaceuticals TRVN Trevena CLDX Celldex Therapeutics ACRX AcelRx Pharmaceuticals ANAB AnaptysBio CTMX CytomX Therapeutics IOVA Iovance Biotherapeutics LUMO Lumos Pharma KDMN Kadmon Holdings ZYNE Zynerba Pharmaceuticals STML Stemline Therapeutics XENE Xenon Pharmaceuticals ARDX Ardelyx GLYC GlycoMimetics KALA Kala Pharmaceuticals NK NantKwest OBSV ObsEva SA VSTM Verastem NERV Minerva Neurosciences ZNTL Zentalis Pharmaceuticals Llc ADVM Adverum Biotechnologies

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9

$3.01 (50.25%)

40

8 days ago

0/6 (0%)

$1.7 (23.29%)

Buy

162.9

$156.91 (2619.53%)

162.9

1 years 4 months 11 days ago

1/4 (25%)

$125.81 (339.20%)

618

Buy

235.53

$229.54 (3832.05%)

2 years 10 months 19 days ago

0/1 (0%)

$109.92 (87.51%)

Buy

6.87

$5.74 (507.96%)

3 years 4 months 10 days ago

0/1 (0%)

$3.72 (118.10%)

Buy

7

$4.56 (186.89%)

7 years 3 months 6 days ago

0/2 (0%)

$4.6 (103.40%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Biren Amin?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?